PhaseRx, Inc. (PZRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 10, 2025
PhaseRx Market Cap
PhaseRx has a market cap or net worth of $12 as of December 26, 2025. Its market cap has decreased by -99.97% in one year.
Market Cap
12.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 18, 2016, PhaseRx's market cap has decreased from 58.15M to 12.00, a decrease of -100.00%. That is a compound annual growth rate of -79.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 12.00 | -99.49% |
| Dec 31, 2021 | 2.34K | -92.59% |
| Dec 31, 2020 | 31.61K | 285.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 359.24M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |